| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.7 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |